//August 26, 2014
BioMed Realty, of Rockville, a commercial real estate company dealing in the life science industry, announced that GlycoMimetics Inc. has signed a lease for one building of approximately 33,800 square feet at the Center for Life Science | Shady Grove in Rockville. GlycoMimetics is a clinical-stage biotechnology company focused on the development of drugs to treat diseases based on an understanding of the role of carbohydrates in biological processes, and the building at 9708 Medical Center Drive will serve as its corporate headquarters. GlycoMimetics has signed a partnership with Pfizer for a treatment for sickle cell disease that is about to begin Phase 3 trials. The Center for Life Science | Shady Grove is a four-building campus with approximately 214,700 square feet of laboratory and office space.
Sign up for your daily digest of Maryland News.
Attorney Grievance Commission names 2 finalists for Maryland bar counsel
6/6/2023
Treasurer’s choice for Md. 529 administrator confounds plan holders
5/6/2023
Families’ college savings values still unclear as treasurer takes over Md.[...]
2/6/2023
Baltimore poised to settle CSX lawsuit over water main break that derailed train
2/6/2023
Senate gives final approval to debt ceiling deal, sending it to Biden
2/6/2023
House Republicans ready contempt vote against FBI director Wray over Biden docum[...]
6/6/2023
PGA Tour and European tour agree to merge with Saudis, end LIV Golf feud
6/6/2023
Coinbase targeted by SEC in latest shot at crypto firms for allegedly skirting s[...]
6/6/2023
Microsoft will pay $20M to settle charges of illegally collecting children’[...]
6/6/2023
Merck sues feds, calling plan to negotiate Medicare drug prices ‘extortion[...]
6/6/2023
Submit an entry for the business calendar